84
Participants
Start Date
May 1, 2024
Primary Completion Date
June 30, 2025
Study Completion Date
September 30, 2026
Furmonertinib
Drug: Furmonertinib
RECRUITING
Changhai Hospital, Shanghai
The General Hospital of Eastern Theater Command
OTHER
Shanghai Chest Hospital
OTHER
Fujian Provincial Hospital
OTHER
Shanghai Changzheng Hospital
OTHER
The First Affiliated Hospital of Bengbu Medical University
OTHER
The First People's Hospital of Changzhou
OTHER
Second Affiliated Hospital of Wannan Medical College
OTHER
Changhai Hospital
OTHER